The ROI of Smarter Trials: Q&A with Raj Indupuri
News
AI Appreciation Day 2026: As Agentic AI Redefines the Enterprise Playbook
By David Marshall
Venu Mallarapu, Chief Transformation & AI Officer, eClinical Solutions
AI is reshaping the life sciences industry, most notably in analyzing increasingly complex clinical trial data, automating repetitive processes, and surfacing insights faster without compromising quality, ultimately reducing cycle times, getting drugs to patients faster. However, real promise is in moving past efficiency gains, where we’re already seeing measurable ROI in, to the next frontier of clinical data intelligence. By combining AI agents with governed data, explainable intelligence, and human oversight within one platform, AI will transition from a standalone tool to an intelligent operating layer, driving tomorrow’s breakthroughs.
Chief Transformation and AI Officer
Venu Mallarapu is an executive leader at the intersection of AI strategy, clinical data innovation, and large-scale operational transformation. As Chief Transformation and AI Officer at eClinical Solutions, he defines and leads the company’s enterprise AI strategy in partnership with the CEO, with board-level oversight, translating vision into execution across the organization and its client base.
Since 2025, Venu has spearheaded eClinical’s Enterprise AI initiative, establishing the governance framework, value measurement framework, and technology strategy driving toward a 20% enterprise-wide productivity improvement. Working with partners including OpenAI, Anthropic, AWS, Databricks, and Snowflake he is helping embed intelligent capabilities across the elluminate Clinical Data Cloud® and eClinical’s global delivery model.
By submitting, you agree to the processing of your personal data by eClinical Solutions as described in our Privacy Policy.
